Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) treated with pomalidamide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes (PROs) in APOLLO.

被引：1
|
作者：
Terpos, Evangelos
Dimopoulos, Meletios A.
Boccadoro, Mario
Delimpasi, Sosana
Beksac, Meral
Katodritou, Eirini
Moreau, Philippe
Baldini, Luca
Symeonidis, Argiris
Bila, Jelena
Oriol, Albert
Mateos, Maria-Victoria
Einsele, Hermann
Orfanidis, Ioannis
Gries, Katharine S.
Fastenau, John
Kampfenkel, Tobias
Qiu, Yanping
Amin, Himal
Sonneveld, Pieter
机构：
[1] Natl & Kapodistrian Univ Athens, Athens, Greece
[2] Univ Torino, Turin, Italy
[3] Gen Hosp Evangelismos, Athens, Greece
[4] Ankara Univ, Ankara, Turkey
[5] Theagen Canc Hosp, Thessaloniki, Greece
[6] Univ Hosp, Hotel Dieu, Hematol, Nantes, France
[7] Univ Milan, Milan, Italy
[8] Univ Patras, Patras, Greece
[9] Univ Belgrade, Belgrade, Serbia
[10] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Barcelona, Spain
[11] Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Barcelona, Spain
[12] Univ Hosp Salamanca, IBSAL, Canc Res Ctr IBMCC USAL CSIC, Salamanca, Spain
[13] Wurzburg Univ, Med Ctr, Wurzburg, Germany
[14] Hlth Data Specialists SA, Dublin, Ireland
[15] Janssen Res & Dev LLC, Raritan, NJ USA
[16] Janssen Res & Dev LLC, Leiden, NJ, Netherlands
[17] Janssen Res & Dev LLC, Beijing, Peoples R China
[18] Erasmus Univ, Med Ctr, Canc Inst, Rotterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.8046
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8046
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) receiving real-life current standard of care (SOC) in the LocoMMotion study.
    Delforge, Michel
    Moreau, Philippe
    Einsele, Hermann
    De Stefano, Valerio
    Lindsey-Hill, Joanne
    Vincent, Laure
    Mangiacavalli, Silvia
    Perrot, Aurore
    Ocio, Enrique
    ten Seldam, Silene
    in ' t Groen-Damen, Ester
    Semerjian, Maria
    Strulev, Vadim
    Schecter, Jordan Mark
    Roccia, Tito
    Gries, Katharine S.
    Nesheiwat, Tonia
    Wapenaar, Robert
    Mateos, Maria-Victoria
    Weisel, Katja
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [22] Health related quality of life (HRQoL) outcomes from the phase III CANDOR study comparing carfilzomib, dexamethasone, and daratumumab (KdD) to carfilzomib and dexamethasone (Kd) in patients (Pts) with relapsed or refractory multiple myeloma.
    Siegel, David Samuel DiCapua
    Weisel, Katja
    Zahlten-Kumeli, Anita
    Medhekar, Rohan
    Sapra, Sandhya
    Ding, Bifeng
    Leleu, Xavier
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] Health-related quality of life in patients with relapsed/refractory multiple myeloma (RRMM) treated with teclistamab, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody: Patient-reported outcomes in MajesTEC-1.
    Martin, Thomas G.
    Moreau, Philippe
    Usmani, Saad Zafar
    Garfall, Alfred L.
    Mateos, Maria-Victoria
    San-Miguel, Jesus F.
    Rocafiguera, Albert Oriol
    Nooka, Ajay K.
    Rosinol, Laura
    Chari, Ajai
    Karlin, Lionel
    Krishnan, Amrita Y.
    Bahlis, Nizar J.
    Popat, Rakesh
    Besemer, Britta
    Martinez, Joaquin
    Delforge, Michel
    Fastenau, John
    Gries, Katharine S.
    van de Donk, Niels W. C. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Pomalidomide and Dexamethasone with or without Subcutaneous Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma: Updated Analysis of the Phase 3 Apollo Study
    Sonneveld, Pieter
    Terpos, Evangelos
    Boccadoro, Mario
    Delimpasi, Sosana
    Beksac, Meral
    Katodritou, Eirini
    Moreau, Philippe
    Baldini, Luca
    Symeonidis, Argiris
    Bila, Jelena
    Oriol, Albert
    Mateos, Maria-Victoria
    Einsele, Hermann
    Orfanidis, Ioannis
    Kampfenkel, Tobias
    Qiu, Yanping
    Amin, Himal
    Kosh, Michele
    Tran, Nam Phuong
    Carson, Robin
    Dimopoulos, Meletios A.
    BLOOD, 2021, 138
  • [25] A systematic literature review of patient-reported outcomes (PROs) or health-related quality of life (HRQoL) associated with metastatic colorectal cancer (mCRC)
    Amonkar, Mayur
    Chase, Monica
    Takyar, Jitender
    Sharma, Sheetal
    QUALITY OF LIFE RESEARCH, 2021, 30 (SUPPL 1) : S164 - S165
  • [26] PATIENT REPORTED OUTCOMES IN OPTIMIZING MYELOMA PATIENTS' HEALTH-RELATED QUALITY OF LIFE
    King, Tracy A.
    King, Madeline T.
    White, Kate J.
    SEMINARS IN ONCOLOGY NURSING, 2017, 33 (03) : 299 - 315
  • [27] Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) receiving real-life standard of care (SOC) treatments: results from the LocoMMotion study
    Delforge, Michel
    Moreau, Philippe
    Einsele, Hermann
    De Stefano, Valerio
    Lindsey-Hill, Joanne
    Vincent, Laure
    Mangiacavalli, Silvia
    Perrot, Aurore
    Ocio, Enrique
    ten Seldam, Silene
    Groen-Damen, Ester in'T
    Semerjian, Maria
    Strulev, Vadim
    Schecter, Jordan
    Roccia, Tito
    Gries, Katharine
    Nesheiwat, Tonia
    Wapenaar, Robert
    Mateos, Maria-Victoria
    Weisel, Katja
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S166 - S167
  • [28] Health Related Quality of Life (HRQoL) in Relapsed/Refractory Multiple Myeloma (RRMM): A Systematic Literature Review (SLR) and Meta-Analysis
    Banerjee, Rahul
    Hasegawa, Ken
    Itani, Taha
    Giordana, Monique
    Granados, Enrique
    Rosado, Margrit B.
    Chan, Rebecca J.
    Kostic, Ana
    Kanters, Steve
    Zoratti, Michael J.
    Leleu, Xavier
    BLOOD, 2024, 144 : 4721 - 4722
  • [29] Health-related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial
    Hungria, Vania
    Beksac, Meral
    Weisel, Katja C.
    Nooka, Ajay K.
    Masszi, Tamas
    Spicka, Ivan
    Munder, Markus
    Mateos, Maria-Victoria
    Mark, Tomer M.
    Qi, Ming
    Qin, Xiang
    Fastenau, John
    Spencer, Andrew
    Sonneveld, Pieter
    Garvin, Wendy
    Renaud, Thomas
    Gries, Katharine S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (03) : 561 - 569
  • [30] Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma Treated with Isatuximab Plus Pomalidomide and Dexamethasone: Icaria-MM Study
    Houghton, Katherine
    Dimopoulos, Meletios A.
    Lin, Peggy
    Guillonneau, Sophie
    Bury, Denise
    Attal, Michel
    Richardson, Paul G.
    Delforge, Michel
    BLOOD, 2019, 134
12345